CPAC Systems AB Announces Strategic Minority Investment in Flying Fish
Accelerating the shift toward sustainable and intelligent water mobility GOTHENBURG, Sweden–(BUSINESS WIRE)–CPAC Systems AB, a leader in advanced control... Read more.
Algonquin Power & Utilities Corp. Announces 2025 First Quarter Financial Results; Plans to Host Investor Update Call on June 3
OAKVILLE, Ontario–(BUSINESS WIRE)–Algonquin Power & Utilities Corp. (TSX/NYSE: AQN) (“AQN” or the “Company”) announced today financial results... Read more.
Algonquin Power & Utilities Corp. Declares Second Quarter 2025 Common Share Dividend of U.S.$0.0650 (C$0.0897), and Declares Second Quarter 2025 Preferred Share Dividends
OAKVILLE, Ontario–(BUSINESS WIRE)–Algonquin Power & Utilities Corp. (“AQN”) (TSX: AQN, AQN.PR.A, AQN.PR.D, NYSE: AQN) announced today that its... Read more.
Essent Group Ltd. Announces First Quarter 2025 Results and Declares Quarterly Dividend
HAMILTON, Bermuda–(BUSINESS WIRE)–Essent Group Ltd. (NYSE: ESNT) today reported net income for the quarter ended March 31, 2025 of $175.4 million or... Read more.
Teletrac Navman’s Asset Trackers Honored as a 2025 Concrete Contractor Top Products Award Winner
NORTHBROOK, Ill.–(BUSINESS WIRE)–Teletrac Navman, a leading connected mobility platform and Vontier company, today announces that Teletrac Navman Asset... Read more.
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
HBsAg loss 24 weeks post-end of treatment achieved in 17% and 21% of participants with low baseline HBsAg receiving tobevibart + elebsiran without or with PEG-IFNα,... Read more.
Docebo Reports First Quarter 2025 Results
TORONTO–(BUSINESS WIRE)–Docebo Inc. (NASDAQ: DCBO; TSX:DCBO) (“Docebo” or the “Company”), a leading learning platform provider with a foundation... Read more.
LEO Pharma announces Positive Topline Phase 2b Results for Temtokibart in Moderate-to-Severe Atopic Dermatitis
Temtokibart achieved positive results for the primary endpoint for the 3 highest doses in a phase 2b clinical trial in adults with moderate-to-severe atopic dermatitis... Read more.
American Strategic Investment Co. Announces First Quarter 2025 Results
Company to Host Investor Webcast and Conference Call Today at 11:00 AM ET NEW YORK–(BUSINESS WIRE)–American Strategic Investment Co. (NYSE: NYC) (“ASIC”... Read more.
Nidec Announces the Withdrawal of the Tender Offer for Makino Milling Machine Co., Ltd. (Securities Code: 6135)
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594) (OTC US: NJDCY) (“Nidec” or the “Company”) announced that the Company decided to... Read more.